Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지

Pyloric Obstruction with Advanced Gastric Cancer: Stent vs. Bypass

악성 위출구 폐쇄 치료의 선택: 스텐트 삽입술 혹은 수술적 우회술?

  • Lee, Beom-Jae (Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine) ;
  • Park, Jong-Jae (Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine)
  • 이범재 (고려대학교 의과대학 소화기내과학교실) ;
  • 박종재 (고려대학교 의과대학 소화기내과학교실)
  • Received : 2009.03.09
  • Accepted : 2009.03.23
  • Published : 2009.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

In the past, conservative bypass surgery was usually performed for palliation of malignant obstruction of the gastrointestinal tract. However, endoscopic stenting was developed recently, and technical advances and clinical experience have made it possible to establish stent implantation as one of the main treatment options. There are several advantages in stent implantation over bypass surgery, such as high feasibility and technical success rate, non-invasiveness, rapid symptomatic response, short hospitalization, and cost-effect benefits. Complications, such as stent ingrowth, stent injury by bile or acid, and migration, may occur and early re-insertion is frequently needed. Recently, diverse novel stents which are powered to predict stent migration or ingrowth have been developed and are being used in the clinical setting. In general, stent implantation is known to be beneficial in patients who are expected to survive <6 months, and surgical bypass may be more effective in patients who can survive >6 months. In this review, we have compared the technical feasibility, clinical outcomes, complications, and cost-benefit between stent implantation and bypass surgery, and determined the optimal treatment strategy in malignant upper gastrointestinal obstruction.

악성 위장관 협착에 의한 폐쇄 증상의 개선을 위하여 과거에는 고식적인 수술적 우회술을 주로 시행하였으나, 최근 내시경적 스텐트 삽입술이 개발되고 기술적 진보와 임상 경험이 축적됨에 따라 새로운 치료 방침의 하나로 확립되었다. 스텐트 삽입술은 고식적 우회술에 비해 시술이 간편하여 성공률이 높고 비침습적이며 단기간에 증상을 개선시키고 시술과 관련된 이환률이 적다는 장점이 있으며 시술에 필요한 입원기간이 짧고 비용면에서 더욱 효과적일 수 있다. 반면 종양의 스텐트 내발육 혹은 위산이나 담즙에 의한 스텐트 손상, 스텐트 일탈 등의 합병증이 발생하여 폐쇄 증상이 조기에 재발하고 재시술이 필요할 수 있다는 문제점이 있어 최근에는 스텐트 일탈을 예방하고 종양의 내발육을 극복할 수 있는 다양한 종류의 스텐트가 개발되어 임상에 응용되고 있다. 일반적으로 악성 위장관 폐쇄에 의한 폐쇄 증상의 완화를 목적으로 하는 스텐트 삽입술은 기대 여명이 6개월 이하인 환자에서 효과적이고 그 이상의 생존이 기대되는 환자에서는 고식적 우회술을 시행하는 것이 적합한 치료 방침으로 생각된다. 본 종설에서는 악성 위출구 폐쇄 환자의 치료에서 쟁점이 되고 있는 스텐트 삽입술과 수술적 우회술 중 어떤 치료가 보다 적절한가를 판단하기 위해서 기술적 측면, 임상 증상의 개선, 합병증, 비용 대비 효과 등을 문헌 고찰을 통해 비교함으로써 적절한 치료 방법의 선택에 대한 해답을 찾고자 한다.

Keywords

References

  1. Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007;8:7-18.
  2. Park JJ. Which patient and which stent?- pylorus and duodenum. Korean J Gastrointest Endosc 2007;34(Suppl.2):128-132.
  3. Simmons DT, Baron TH. Endoluminal palliation. Gastrointest Endosc Clin N Am 2005;15:467-484. https://doi.org/10.1016/j.giec.2005.03.005
  4. Moon JS. Upper GI stenting: detailed techniques in esophageal and pyloric stenting. Korean J Gastrointest Endosc 2006;32(Suppl.1):158-163.
  5. van Hooft J, Mutignani M, Repici A, Messmann H, Neuhaus H, Fockens P. First data on the palliative treatment of patients with malignant gastric outlet obstruction using the WallFlex enteral stent: a retrospective multicenter study. Endoscopy 2007;39:434-439. https://doi.org/10.1055/s-2007-966338
  6. Kim JH. Post-stenting management and treatment of complications. Korean J Gastrointest Endosc 2006;32(Suppl.1):174-180.
  7. Holt AP, Patel M, Ahmed MM. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest Endosc 2004;60:1010-1017. https://doi.org/10.1016/S0016-5107(04)02276-X
  8. Laasch HU, Martin DF, Maetani I. Enteral stents in the gastric outlet and duodenum. Endoscopy 2005;37:74-81. https://doi.org/10.1055/s-2004-826103
  9. Park SJ. UGI stents: covered or non-covered. Korean J Gastrointest Endosc 2005;30(Suppl.1):230-235.
  10. Jeurnink SM, Steyerberg EW, Hof GV, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 2007;96:389-396. https://doi.org/10.1002/jso.20828
  11. Kim JH. Pyloric stenting for malignant gastroduoenal obstruction; the Korean experience. Digestive endoscopy 2006;18:108-113. https://doi.org/10.1111/j.1443-1661.2006.00587.x
  12. Kim GH, Kang DH, Lee DH, Heo J, Song GA, Cho M, Yang US. Which types of stent, uncovered or covered, should be used in gastric outlet obstructions? Scand J Gastroenterol 2004;39:1010-1014. https://doi.org/10.1080/00365520410003146
  13. Kim TO, Kang DH, Kim GH, Heo J, Song GA, Cho M, Kim DH, Sim MS. Self-expandable metallic stents for palliation of patients with malignant gastric outlet obstruction caused by stomach cancer. World J Gastroenterol 2007;13:916-920. https://doi.org/10.3748/wjg.v13.i6.916
  14. Song GA, Kang DH, Kim TO, Heo J, Kim GH, Cho M, Heo JH, Kim JY, Lee JS, Jeoung YJ. Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery: uncovered versus simultaneously deployed uncovered and covered (double) self-expandable metal stents. Gastrointest Endosc 2007;65:782-787. https://doi.org/10.1016/j.gie.2006.08.030
  15. Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, Lee GH, Lee SK, Kim MH, et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007;66:256-264. https://doi.org/10.1016/j.gie.2006.12.017
  16. Jeong JY, Han JK, Kim AY, Lee KH, Lee JY, Kang JW, Kim TJ. Fluoroscopically guided placement of a covered selfexpandable metallic stent for malignant antroduodenal obstructions: Preliminary results in 18 patients. AJR Am J Roentgenol 2002;178:847-852. https://doi.org/10.2214/ajr.178.4.1780847
  17. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents:experience in 36 patients. Am J Gastroenterol 2002;97:72-78. https://doi.org/10.1111/j.1572-0241.2002.05423.x
  18. Jung GS, Song HY, Seo TS, Park SJ, Koo JY, Huh JD. Malignant gastric outlet obstructions: treatment by means of coaxial placement of uncovered and covered expandable nitinol stents. J Vasc Interv Radiol 2002;13:275-283. https://doi.org/10.1016/S1051-0443(07)61720-5
  19. Telford JJ, Carr-Locke DL, Baron TH, Tringali A, Parsons WG, Gabbrielli A, Costamagna G. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004;60:916-920. https://doi.org/10.1016/S0016-5107(04)02228-X
  20. Maetani I, Isayama H, Mizumoto Y. Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study. Gastrointest Endosc 2007;66:355-360. https://doi.org/10.1016/j.gie.2006.11.060
  21. el-Shabrawi A, Cerwenka H, Bacher H, Schweiger J, Kornprat P, Mischinger HJ. Treatment of malignant gastric outlet obstruction: endoscopic implanatation of self-expanding metal stents versus gastric bypass surgery. Eur Surg 2006:38:451-455. https://doi.org/10.1007/s10353-006-0295-z
  22. Dormann A, Meisner S, Verin N, Wenk Lang A. Self- expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004;36:543-550. https://doi.org/10.1055/s-2004-814434